The Spiegel Lab focuses on developing new synthetic approaches that will facilitate our understanding and treatment of human disease. Ongoing project areas of interest to the group include:

1. The development of synthetic molecules capable of refocusing the human immune system towards diseased or infected tissues.

2. Total syntheses of complex natural products found in humans. Synthetic access to these materials will allow us to elucidate disease pathways, with an eye toward therapeutics development.